Table of Content



1. Research Scope & Methodology
1.1. Study Objectives
1.2. Scope Of Study
1.3. Methodology
1.4. Assumptions & Limitations

2. Executive Summary
2.1. Market Size & Estimates
2.2. Market Overview

3. Market Dynamics
3.1. Key Drivers
3.1.1. Prevailing Awareness About Post-Menopausal Issues Among Women
3.1.2. Incidence Of Hormonal Disorders
3.1.3. Product Launches By Major Players
3.2. Key Restraints
3.2.1. Adverse Reactions Associated With Hormone Replacement Therapy
3.2.2. High Cost Of Treatment

4. Key Analytics
4.1. Impact Of Covid-19 On Hormone Replacement Therapy Market
4.2. Key Market Trends
4.3. Porter’S Five Forces Analysis
4.3.1. Buyers Power
4.3.2. Suppliers Power
4.3.3. Substitution
4.3.4. New Entry
4.3.5. Industry Rivalry
4.4. Opportunity Matrix
4.5. Vendor Landscape

5. Market By Therapy Type
5.1. Estrogen Hormone Replacement Therapy
5.2. Thyroid Hormone Replacement Therapy
5.3. Testosterone Hormone Replacement Therapy
5.4. Human Growth Hormone Replacement Therapy
5.5. Progestogen Hormone Replacement Therapy

6. Market By Indication
6.1. Menopause
6.2. Male Hypogonadism
6.3. Growth Hormone Deficiency
6.4. Hypothyroidism
6.5. Other Indications

7. Market By Route Of Administration
7.1. Oral
7.2. Parenteral
7.3. Transdermal
7.4. Other Route Of Administrations

8. Geographical Analysis
8.1. Europe
8.1.1. Market Size & Estimates
8.1.2. Key Growth Enablers
8.1.3. Key Challenges
8.1.4. Key Players
8.1.5. Country Analysis
8.1.5.1. Germany
8.1.5.2. France
8.1.5.3. The United Kingdom
8.1.5.4. Italy
8.1.5.5. Russia
8.1.5.6. Belgium
8.1.5.7. Poland
8.1.5.8. Rest Of Europe

9. Competitive Landscape
9.1. Key Strategic Developments
9.1.1. Mergers & Acquisitions
9.1.2. Product Launches & Developments
9.1.3. Partnerships & Agreements
9.1.4. Business Expansions, Announcements & Divestitures
9.2. Company Profiles
9.2.1. Abbott Laboratories
9.2.2. Amgen
9.2.3. Ani Pharmaceuticals
9.2.4. Bayer Ag
9.2.5. Eli Lilly & Company
9.2.6. Genentech Inc
9.2.7. Ipsen
9.2.8. Merck Kgaa
9.2.9. Novartis Ag
9.2.10. Noven Pharmaceuticals Inc
9.2.11. Novo Nordisk A/S
9.2.12. Pfizer Inc
9.2.13. Viatris Inc (Mylan Nv)



List of Figures


List of Figures


Figure 1: Key Market Trends
Figure 2: Porter’S Five Forces Analysis
Figure 3: Opportunity Matrix
Figure 4: Vendor Landscape
Figure 5: Europe Hormone Replacement Therapy Market, By Therapy Type, In 2020
Figure 6: Europe Hormone Replacement Therapy Market, By Estrogen Hormone Replacement Therapy, 2021-2028 (In $ Million)
Figure 7: Europe Hormone Replacement Therapy Market, By Thyroid Hormone Replacement Therapy, 2021-2028 (In $ Million)
Figure 8: Europe Hormone Replacement Therapy Market, By Testosterone Hormone Replacement Therapy, 2021-2028 (In $ Million)
Figure 9: Europe Hormone Replacement Therapy Market, By Human Growth Hormone Replacement Therapy, 2021-2028 (In $ Million)
Figure 10: Europe Hormone Replacement Therapy Market, By Progestogen Hormone Replacement Therapy, 2021-2028 (In $ Million)
Figure 11: Europe Hormone Replacement Therapy Market, By Indication, In 2020
Figure 12: Europe Hormone Replacement Therapy Market, By Menopause, 2021-2028 (In $ Million)
Figure 13: Europe Hormone Replacement Therapy Market, By Male Hypogonadism, 2021-2028 (In $ Million)
Figure 14: Europe Hormone Replacement Therapy Market, By Growth Hormone Deficiency, 2021-2028 (In $ Million)
Figure 15: Europe Hormone Replacement Therapy Market, By Hypothyroidism, 2021-2028 (In $ Million)
Figure 16: Europe Hormone Replacement Therapy Market, By Other Indications, 2021-2028 (In $ Million)
Figure 17: Europe Hormone Replacement Therapy Market, By Route Of Administration, In 2020
Figure 18: Europe Hormone Replacement Therapy Market, By Oral, 2021-2028 (In $ Million)
Figure 19: Europe Hormone Replacement Therapy Market, By Parenteral, 2021-2028 (In $ Million)
Figure 20: Europe Hormone Replacement Therapy Market, By Transdermal, 2021-2028 (In $ Million)
Figure 21: Europe Hormone Replacement Therapy Market, By Other Route Of Administrations, 2021-2028 (In $ Million)
Figure 22: Europe Hormone Replacement Therapy Market, Country Outlook, 2020 & 2028 (In %)
Figure 23: Germany Hormone Replacement Therapy Market, 2021-2028 (In $ Million)
Figure 24: France Hormone Replacement Therapy Market, 2021-2028 (In $ Million)
Figure 25: United Kingdom Hormone Replacement Therapy Market, 2021-2028 (In $ Million)
Figure 26: Italy Hormone Replacement Therapy Market, 2021-2028 (In $ Million)
Figure 27: Russia Hormone Replacement Therapy Market, 2021-2028 (In $ Million)
Figure 28: Belgium Hormone Replacement Therapy Market, 2021-2028 (In $ Million)
Figure 29: Poland Hormone Replacement Therapy Market, 2021-2028 (In $ Million)
Figure 30: Rest Of Europe Hormone Replacement Therapy Market, 2021-2028 (In $ Million)


List of Tables


List of Tables


TABLE 1: MARKET SNAPSHOT - HORMONE REPLACEMENT THERAPY
TABLE 2: EUROPE HORMONE REPLACEMENT THERAPY MARKET, BY THERAPY TYPE, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
TABLE 3: EUROPE HORMONE REPLACEMENT THERAPY MARKET, BY THERAPY TYPE, FORECAST YEARS, 2021-2028 (IN $ MILLION)
TABLE 4: EUROPE HORMONE REPLACEMENT THERAPY MARKET, BY INDICATION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
TABLE 5: EUROPE HORMONE REPLACEMENT THERAPY MARKET, BY INDICATION, FORECAST YEARS, 2021-2028 (IN $ MILLION)
TABLE 6: EUROPE HORMONE REPLACEMENT THERAPY MARKET, BY ROUTE OF ADMINISTRATION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
TABLE 7: EUROPE HORMONE REPLACEMENT THERAPY MARKET, BY ROUTE OF ADMINISTRATION, FORECAST YEARS, 2021-2028 (IN $ MILLION)
TABLE 8: EUROPE HORMONE REPLACEMENT THERAPY MARKET, BY COUNTRY, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
TABLE 9: EUROPE HORMONE REPLACEMENT THERAPY MARKET, BY COUNTRY, FORECAST YEARS, 2021-2028 (IN $ MILLION)
TABLE 10: LEADING PLAYERS OPERATING IN EUROPE HORMONE REPLACEMENT THERAPY MARKET
TABLE 11: LIST OF MERGERS & ACQUISITIONS
TABLE 12: LIST OF PRODUCT LAUNCHES & DEVELOPMENTS
TABLE 13: LIST OF PARTNERSHIPS & AGREEMENTS
TABLE 14: LIST OF BUSINESS EXPANSIONS, ANNOUNCEMENTS, AND DIVESTITURES